Senores Pharmaceuticals Limited
SENORES

Senores Pharmaceuticals Limited

Pharmaceuticals
Share price
1,513
Market cap
₹6,976 Cr
1Y return
117%

A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.

Investors holding Senores Pharmaceuticals Limited

HSBC Mutual Fund
HSBC Mutual Fund
Mutual Fund
3.44%
AC
Astorne Capital
Foreign Investor
1.95%

Latest move

ICICI Prudential Mutual FundExited
ICICI Prudential Mutual Fund, which previously held 1.37 percent of Senores Pharmaceuticals Limited, has dropped off the company's disclosed shareholder list, indicating either a complete exit or a reduction below the 1 percent reporting threshold.
20 Jul 2026Sign in to read more

Whales made 11 more moves in Senores Pharmaceuticals Limited

Sign in to see who is buying and selling.

Sign in to find out
Senores Pharmaceuticals — investor holdings · WhaleWatch